X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology (87) 87
humans (83) 83
index medicus (74) 74
transplantation (68) 68
adult (57) 57
female (57) 57
male (55) 55
middle aged (54) 54
hematology, oncology and palliative medicine (52) 52
aged (40) 40
article (36) 36
hematopoietic stem cells (34) 34
adolescent (33) 33
oncology (31) 31
leukemia (29) 29
cancer (28) 28
stem cells (28) 28
young adult (25) 25
analysis (22) 22
chemotherapy (22) 22
hemic and lymphatic diseases (21) 21
care and treatment (20) 20
stem-cell transplantation (20) 20
survival (20) 20
immunology (19) 19
research (18) 18
treatment outcome (18) 18
prognosis (17) 17
retrospective studies (17) 17
bone marrow (16) 16
disease-free survival (16) 16
hematopoietic stem cell transplantation (16) 16
transplantation, homologous (16) 16
hematopoietic stem cell transplantation - methods (15) 15
therapy (15) 15
acute myeloid leukemia (14) 14
bone-marrow-transplantation (14) 14
health aspects (14) 14
acute disease (13) 13
survival rate (13) 13
abridged index medicus (12) 12
survival analysis (12) 12
acute lymphoblastic-leukemia (11) 11
acute lymphocytic leukemia (11) 11
acute myelogenous leukemia (11) 11
acute myeloid-leukemia (11) 11
aged, 80 and over (11) 11
antineoplastic agents - therapeutic use (11) 11
cytogenetics (11) 11
patient outcomes (11) 11
precursor cell lymphoblastic leukemia-lymphoma - therapy (11) 11
acute lymphoblastic leukemia (10) 10
diagnosis (10) 10
mortality (10) 10
recurrence (10) 10
risk factors (10) 10
adults (9) 9
aml (9) 9
clinical trials (9) 9
hematopoietic stem cell transplantation - adverse effects (9) 9
kaplan-meier estimate (9) 9
leukemia, myeloid, acute - drug therapy (9) 9
minimal residual disease (9) 9
transplantation conditioning (9) 9
acute lymphocytic-leukemia (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
child (8) 8
cytarabine (8) 8
leukemia, myeloid, acute - genetics (8) 8
leukemia, myeloid, acute - mortality (8) 8
mutation (8) 8
myelodysplastic syndrome (8) 8
oncology, experimental (8) 8
relapse (8) 8
transplantation, autologous (8) 8
age factors (7) 7
animals (7) 7
bone marrow transplantation (7) 7
child, preschool (7) 7
graft vs host disease - etiology (7) 7
hematopoietic-cell transplantation (7) 7
immunotherapy (7) 7
infant (7) 7
medical colleges (7) 7
medicine, general & internal (7) 7
philadelphia chromosome (7) 7
randomized-trial (7) 7
risk (7) 7
surgical procedures, operative (7) 7
versus-host-disease (7) 7
allogeneic (6) 6
allogeneic transplantation (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
bone-marrow (6) 6
bone-marrow transplantation (6) 6
combined modality therapy (6) 6
cyclophosphamide (6) 6
hyper-cvad (6) 6
medical research (6) 6
patients (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 8, pp. 1061 - 1075
Journal Article
Chest, ISSN 0012-3692, 2014, Volume 146, Issue 4, pp. 985A - 985A
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 142, Issue 4, pp. 307A - 307B
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 2, pp. S275 - S275
Journal Article
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2008, Volume 27, Issue 8, pp. 823 - 829
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 23, Issue 1, pp. 165 - 171
Highlights • Donation-related HRQoL among older sibling HSC donors >60 is similar to that of their younger counterparts 18-60. • Among older sibling HSC donors... 
Hematology, Oncology and Palliative Medicine | HSC donation | related donation | HSC donor HRQoL
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 9, pp. 1478 - 1484
Highlights • Infliximab was associated with early clinical responses that were not durable • There were no variables as significant predictors of response to... 
Hematology, Oncology and Palliative Medicine | Tumor necrosis factor alpha blockade | Acute graft-versus-host disease | Allogeneic hematopoietic cell transplantation | RHEUMATOID-ARTHRITIS | BONE-MARROW-TRANSPLANTATION | ACUTE GVHD | TUBERCULOSIS | RANDOMIZED-TRIAL | RISK | NECROSIS-FACTOR-ALPHA | INVASIVE FUNGAL-INFECTIONS | IMMUNOLOGY | RECIPIENTS | TRANSPLANTATION | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Graft vs Host Disease - therapy | Hematologic Neoplasms - therapy | Bone Marrow - immunology | Injections, Intravenous | Myeloablative Agonists - adverse effects | Bacterial Infections - etiology | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Hematologic Neoplasms - pathology | Adrenal Cortex Hormones - therapeutic use | Graft vs Host Disease - immunology | Infliximab - administration & dosage | Transplantation, Homologous | Infliximab - adverse effects | Graft vs Host Disease - mortality | Bacterial Infections - immunology | Tumor Necrosis Factor-alpha - immunology | Adult | Female | Transplantation Conditioning - adverse effects | Retrospective Studies | Bone Marrow - drug effects | Acute Disease | Virus Diseases - immunology | Drug Administration Schedule | Hematopoietic Stem Cell Transplantation | Treatment Outcome | Graft vs Host Disease - pathology | Virus Diseases - etiology | Bacterial Infections - pathology | Bone Marrow - pathology | Mycoses - pathology | Virus Diseases - pathology | Survival Analysis | Aged | Virus Diseases - mortality | Hematologic Neoplasms - immunology | Mycoses - mortality | Mycoses - etiology | Mycoses - immunology | Tumor Necrosis Factor-alpha - biosynthesis | Bacterial Infections - mortality | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Infliximab | Political corruption | Medical research | Bacterial infections | Mortality | Mycoses | Medicine, Experimental | Transplantation | Health aspects | Hematopoietic stem cells | Index Medicus
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2015, Volume 90, Issue 12, pp. 1623 - 1638
Abstract Objectives To share our 25 years of experience with patients with primary myelodysplastic syndromes (MDS) and to describe the natural history of the... 
Internal Medicine
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.